A rare case of eptifibatide-induced thrombocytopenia

Eptifibatide is a glycoprotein (GP) IIb/IIIa receptor antagonist, used for the treatment of acute coronary syndrome with high-risk features or ongoing ischemia. Several case reports have described thrombocytopenia as a rare side effect of eptifibatide administration. The exact mechanism remains uncl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamar, Khalil, MacDougall, Kira, Alsheikh, Mira, Parylo, Sara, Skaradinskiy, Yevgeniy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043518/
https://www.ncbi.nlm.nih.gov/pubmed/33889336
http://dx.doi.org/10.1080/20009666.2021.1871802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043518/
https://www.ncbi.nlm.nih.gov/pubmed/33889336
http://dx.doi.org/10.1080/20009666.2021.1871802

Ejemplares similares